Global Frataxin Mitochondrial Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Report ID: GIR2212270012 | Category: Pharma & Healthcare | Pages: 119 | Format: PDF | Published Date: February 03,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) – Frataxin is a protein encoded by the FXN gene. It promotes the biosynthesis of heme and assembly and repair of iron-sulfur clusters by delivering Fe2+ to proteins involved in these pathways. It plays a role in the protection against iron-catalyzed oxidative stress through its ability to catalyze the oxidation of Fe2+ to Fe3.
According to our (Global Info Research) latest study, the global Frataxin Mitochondrial market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Frataxin Mitochondrial market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Frataxin Mitochondrial market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Frataxin Mitochondrial market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Frataxin Mitochondrial market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Frataxin Mitochondrial market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Frataxin Mitochondrial
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Frataxin Mitochondrial market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AavantiBio Inc, Adverum Biotechnologies Inc, Anima Biotech Inc, Biointaxis SL and Cellivery Therapeutics Inc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Frataxin Mitochondrial market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    Friedreich Ataxia Protein
    FXN
    EC 1.16.3.1
Market segment by Application
    Central Nervous System
    Cardiovascular
Major players covered
    AavantiBio Inc
    Adverum Biotechnologies Inc
    Anima Biotech Inc
    Biointaxis SL
    Cellivery Therapeutics Inc
    CRISPR Therapeutics AG
    Design Therapeutics Inc
    Fratagene Therapeutics Srl
    Fulcrum Therapeutics Inc
    Jupiter Orphan Therapeutics Inc
    Lacerta Therapeutics Inc
    Larimar Therapeutics Inc
    Novartis Gene Therapies
    PTC Therapeutics Inc
    Voyager Therapeutics Inc
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Frataxin Mitochondrial product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Frataxin Mitochondrial, with price, sales, revenue and global market share of Frataxin Mitochondrial from 2018 to 2023.
Chapter 3, the Frataxin Mitochondrial competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Frataxin Mitochondrial breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Frataxin Mitochondrial market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Frataxin Mitochondrial.
Chapter 14 and 15, to describe Frataxin Mitochondrial sales channel, distributors, customers, research findings and conclusion.

1 Market Overview
    1.1 Product Overview and Scope of Frataxin Mitochondrial
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Frataxin Mitochondrial Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Friedreich Ataxia Protein
        1.3.3 FXN
        1.3.4 EC 1.16.3.1
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Frataxin Mitochondrial Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Central Nervous System
        1.4.3 Cardiovascular
    1.5 Global Frataxin Mitochondrial Market Size & Forecast
        1.5.1 Global Frataxin Mitochondrial Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Frataxin Mitochondrial Sales Quantity (2018-2029)
        1.5.3 Global Frataxin Mitochondrial Average Price (2018-2029) 
2 Manufacturers Profiles
    2.1 AavantiBio Inc
        2.1.1 AavantiBio Inc Details
        2.1.2 AavantiBio Inc Major Business
        2.1.3 AavantiBio Inc Frataxin Mitochondrial Product and Services
        2.1.4 AavantiBio Inc Frataxin Mitochondrial Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 AavantiBio Inc Recent Developments/Updates
    2.2 Adverum Biotechnologies Inc
        2.2.1 Adverum Biotechnologies Inc Details
        2.2.2 Adverum Biotechnologies Inc Major Business
        2.2.3 Adverum Biotechnologies Inc Frataxin Mitochondrial Product and Services
        2.2.4 Adverum Biotechnologies Inc Frataxin Mitochondrial Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Adverum Biotechnologies Inc Recent Developments/Updates
    2.3 Anima Biotech Inc
        2.3.1 Anima Biotech Inc Details
        2.3.2 Anima Biotech Inc Major Business
        2.3.3 Anima Biotech Inc Frataxin Mitochondrial Product and Services
        2.3.4 Anima Biotech Inc Frataxin Mitochondrial Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Anima Biotech Inc Recent Developments/Updates
    2.4 Biointaxis SL
        2.4.1 Biointaxis SL Details
        2.4.2 Biointaxis SL Major Business
        2.4.3 Biointaxis SL Frataxin Mitochondrial Product and Services
        2.4.4 Biointaxis SL Frataxin Mitochondrial Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Biointaxis SL Recent Developments/Updates
    2.5 Cellivery Therapeutics Inc
        2.5.1 Cellivery Therapeutics Inc Details
        2.5.2 Cellivery Therapeutics Inc Major Business
        2.5.3 Cellivery Therapeutics Inc Frataxin Mitochondrial Product and Services
        2.5.4 Cellivery Therapeutics Inc Frataxin Mitochondrial Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Cellivery Therapeutics Inc Recent Developments/Updates
    2.6 CRISPR Therapeutics AG
        2.6.1 CRISPR Therapeutics AG Details
        2.6.2 CRISPR Therapeutics AG Major Business
        2.6.3 CRISPR Therapeutics AG Frataxin Mitochondrial Product and Services
        2.6.4 CRISPR Therapeutics AG Frataxin Mitochondrial Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 CRISPR Therapeutics AG Recent Developments/Updates
    2.7 Design Therapeutics Inc
        2.7.1 Design Therapeutics Inc Details
        2.7.2 Design Therapeutics Inc Major Business
        2.7.3 Design Therapeutics Inc Frataxin Mitochondrial Product and Services
        2.7.4 Design Therapeutics Inc Frataxin Mitochondrial Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Design Therapeutics Inc Recent Developments/Updates
    2.8 Fratagene Therapeutics Srl
        2.8.1 Fratagene Therapeutics Srl Details
        2.8.2 Fratagene Therapeutics Srl Major Business
        2.8.3 Fratagene Therapeutics Srl Frataxin Mitochondrial Product and Services
        2.8.4 Fratagene Therapeutics Srl Frataxin Mitochondrial Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Fratagene Therapeutics Srl Recent Developments/Updates
    2.9 Fulcrum Therapeutics Inc
        2.9.1 Fulcrum Therapeutics Inc Details
        2.9.2 Fulcrum Therapeutics Inc Major Business
        2.9.3 Fulcrum Therapeutics Inc Frataxin Mitochondrial Product and Services
        2.9.4 Fulcrum Therapeutics Inc Frataxin Mitochondrial Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Fulcrum Therapeutics Inc Recent Developments/Updates
    2.10 Jupiter Orphan Therapeutics Inc
        2.10.1 Jupiter Orphan Therapeutics Inc Details
        2.10.2 Jupiter Orphan Therapeutics Inc Major Business
        2.10.3 Jupiter Orphan Therapeutics Inc Frataxin Mitochondrial Product and Services
        2.10.4 Jupiter Orphan Therapeutics Inc Frataxin Mitochondrial Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Jupiter Orphan Therapeutics Inc Recent Developments/Updates
    2.11 Lacerta Therapeutics Inc
        2.11.1 Lacerta Therapeutics Inc Details
        2.11.2 Lacerta Therapeutics Inc Major Business
        2.11.3 Lacerta Therapeutics Inc Frataxin Mitochondrial Product and Services
        2.11.4 Lacerta Therapeutics Inc Frataxin Mitochondrial Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Lacerta Therapeutics Inc Recent Developments/Updates
    2.12 Larimar Therapeutics Inc
        2.12.1 Larimar Therapeutics Inc Details
        2.12.2 Larimar Therapeutics Inc Major Business
        2.12.3 Larimar Therapeutics Inc Frataxin Mitochondrial Product and Services
        2.12.4 Larimar Therapeutics Inc Frataxin Mitochondrial Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Larimar Therapeutics Inc Recent Developments/Updates
    2.13 Novartis Gene Therapies
        2.13.1 Novartis Gene Therapies Details
        2.13.2 Novartis Gene Therapies Major Business
        2.13.3 Novartis Gene Therapies Frataxin Mitochondrial Product and Services
        2.13.4 Novartis Gene Therapies Frataxin Mitochondrial Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Novartis Gene Therapies Recent Developments/Updates
    2.14 PTC Therapeutics Inc
        2.14.1 PTC Therapeutics Inc Details
        2.14.2 PTC Therapeutics Inc Major Business
        2.14.3 PTC Therapeutics Inc Frataxin Mitochondrial Product and Services
        2.14.4 PTC Therapeutics Inc Frataxin Mitochondrial Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 PTC Therapeutics Inc Recent Developments/Updates
    2.15 Voyager Therapeutics Inc
        2.15.1 Voyager Therapeutics Inc Details
        2.15.2 Voyager Therapeutics Inc Major Business
        2.15.3 Voyager Therapeutics Inc Frataxin Mitochondrial Product and Services
        2.15.4 Voyager Therapeutics Inc Frataxin Mitochondrial Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 Voyager Therapeutics Inc Recent Developments/Updates
3 Competitive Environment: Frataxin Mitochondrial by Manufacturer
    3.1 Global Frataxin Mitochondrial Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Frataxin Mitochondrial Revenue by Manufacturer (2018-2023)
    3.3 Global Frataxin Mitochondrial Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Frataxin Mitochondrial by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Frataxin Mitochondrial Manufacturer Market Share in 2022
        3.4.2 Top 6 Frataxin Mitochondrial Manufacturer Market Share in 2022
    3.5 Frataxin Mitochondrial Market: Overall Company Footprint Analysis
        3.5.1 Frataxin Mitochondrial Market: Region Footprint
        3.5.2 Frataxin Mitochondrial Market: Company Product Type Footprint
        3.5.3 Frataxin Mitochondrial Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
    4.1 Global Frataxin Mitochondrial Market Size by Region
        4.1.1 Global Frataxin Mitochondrial Sales Quantity by Region (2018-2029)
        4.1.2 Global Frataxin Mitochondrial Consumption Value by Region (2018-2029)
        4.1.3 Global Frataxin Mitochondrial Average Price by Region (2018-2029)
    4.2 North America Frataxin Mitochondrial Consumption Value (2018-2029)
    4.3 Europe Frataxin Mitochondrial Consumption Value (2018-2029)
    4.4 Asia-Pacific Frataxin Mitochondrial Consumption Value (2018-2029)
    4.5 South America Frataxin Mitochondrial Consumption Value (2018-2029)
    4.6 Middle East and Africa Frataxin Mitochondrial Consumption Value (2018-2029)
5 Market Segment by Type
    5.1 Global Frataxin Mitochondrial Sales Quantity by Type (2018-2029)
    5.2 Global Frataxin Mitochondrial Consumption Value by Type (2018-2029)
    5.3 Global Frataxin Mitochondrial Average Price by Type (2018-2029)
6 Market Segment by Application
    6.1 Global Frataxin Mitochondrial Sales Quantity by Application (2018-2029)
    6.2 Global Frataxin Mitochondrial Consumption Value by Application (2018-2029)
    6.3 Global Frataxin Mitochondrial Average Price by Application (2018-2029)
7 North America
    7.1 North America Frataxin Mitochondrial Sales Quantity by Type (2018-2029)
    7.2 North America Frataxin Mitochondrial Sales Quantity by Application (2018-2029)
    7.3 North America Frataxin Mitochondrial Market Size by Country
        7.3.1 North America Frataxin Mitochondrial Sales Quantity by Country (2018-2029)
        7.3.2 North America Frataxin Mitochondrial Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
    8.1 Europe Frataxin Mitochondrial Sales Quantity by Type (2018-2029)
    8.2 Europe Frataxin Mitochondrial Sales Quantity by Application (2018-2029)
    8.3 Europe Frataxin Mitochondrial Market Size by Country
        8.3.1 Europe Frataxin Mitochondrial Sales Quantity by Country (2018-2029)
        8.3.2 Europe Frataxin Mitochondrial Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
    9.1 Asia-Pacific Frataxin Mitochondrial Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Frataxin Mitochondrial Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Frataxin Mitochondrial Market Size by Region
        9.3.1 Asia-Pacific Frataxin Mitochondrial Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Frataxin Mitochondrial Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
    10.1 South America Frataxin Mitochondrial Sales Quantity by Type (2018-2029)
    10.2 South America Frataxin Mitochondrial Sales Quantity by Application (2018-2029)
    10.3 South America Frataxin Mitochondrial Market Size by Country
        10.3.1 South America Frataxin Mitochondrial Sales Quantity by Country (2018-2029)
        10.3.2 South America Frataxin Mitochondrial Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
    11.1 Middle East & Africa Frataxin Mitochondrial Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Frataxin Mitochondrial Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Frataxin Mitochondrial Market Size by Country
        11.3.1 Middle East & Africa Frataxin Mitochondrial Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Frataxin Mitochondrial Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
    12.1 Frataxin Mitochondrial Market Drivers
    12.2 Frataxin Mitochondrial Market Restraints
    12.3 Frataxin Mitochondrial Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
    13.1 Raw Material of Frataxin Mitochondrial and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Frataxin Mitochondrial
    13.3 Frataxin Mitochondrial Production Process
    13.4 Frataxin Mitochondrial Industrial Chain
14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Frataxin Mitochondrial Typical Distributors
    14.3 Frataxin Mitochondrial Typical Customers
15 Research Findings and Conclusion
16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Frataxin Mitochondrial Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?